Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant Among 5.6M Medicare Beneficiaries 65 Years and Older

URL

https://web.archive.org/web/20220126033001/https://www.scribd.com/document/530559640/Effectiveness-of-mRNA-COVID-19-Vaccines-Against-the-Delta-Variant-Among-5-6M-Medicare-Beneficiaries-65-Years-and-Older

Published Date

October 5, 2021

Organization

Joint Artificial Intelligence Center, Department of Defense (JAIC)

Key Excerpts

Slide 2: “Breakthrough infections occurring 6 months after vaccination have an increased risk of hospitalization (odds ratio = 2.5)”

Note: As stated on Slide 11 (below), “60% of COVID-19 hospitalizations” in the 65+ age group “occurred in fully vaccinated individuals in the week ending August 7th.”

Total & breakthrough hospitalizations in the 65 years and older cohort

JAIC was a Department of Defense initiative (source). Works of the United States government are not entitled to domestic copyright protection under U.S. law and are therefore in the public domain.

Medium

document

Topics

breakthrough cases,clinical cases,COVID-19,deaths,hospitalizations,mRNA,vaccines